Luoda is pleased to announce that it has raised approximately $1,000,000 in additional capital from over a dozen external investors in Australia and from abroad. The directors believe this gives Luoda enough resources to ambitiously pursue clinical work on all pipeline products without over-capitalising at a time when it is receiving an encouraging number of inquiries from pharmaceutical companies which may well translate into further financial partnerships. The outcome of these inquiries and negotiations will determine whether a further, flagged (non-dilutive) capital raise will take place later in the year.